Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Alan Harris Stories

2012-07-02 06:24:44

LONDON and NEW YORK, July 2, 2012 /PRNewswire/ -- Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on developing novel first-in-class, synthetic, non-steroidal anti-inflammatory drugs, announced today that it has appointed Alan Harris, M.D., Ph.D., as its Chief Medical Officer. "We are thrilled to welcome Dr. Harris as our Chief Medical Officer," said Dr. David Sidransky, a member of the company's Board of Directors and former Vice Chairman of ImClone Systems, now a...

2011-11-23 22:15:00

Harris & Ruble, a prominent class-action law firm based in Los Angeles announced today they were the first to file a lawsuit against Sutter Health alleging the medical provider did not properly safeguard medical information for more than 4 million of its patients affected by the mid-October theft of a computer from the Sutter Medical Foundation headquarters based in Sacramento, CA. (PRWEB) November 23, 2011 Harris & Ruble, a prominent class-action law firm based in Los Angeles,...

2011-09-13 07:07:00

NEW YORK, Sept. 13, 2011 /PRNewswire/ -- IMMUNE Pharmaceuticals, an emerging leader in the development of Antibody based Therapeutics for the treatment of inflammatory diseases and cancer, today announced the appointment of Dr. Alan Harris, M.D., Ph.D., to the position of Chief Medical Officer. In this new position, Dr. Harris will play a pivotal role in the development of Bertilimumab, IMMUNE's phase II ready fully human monoclonal antibody in development for Crohn's Disease and...

2009-09-09 07:30:00

NEW YORK, Sept. 9 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today that Alan Harris, M.D., Ph.D., the Company's Vice President of Drug Development and Regulatory Affairs, will speak at a conference on Clinical Applications for Age Management Medicine, taking place in Las Vegas, November 5-8, 2009. Dr. Harris's presentation will take place...